Mice deficient in apolipoprotein E but not LDL receptors are resistant to accelerated atherosclerosis associated with obesity

被引:54
作者
Schreyer, SA
Lystig, TC
Vick, CM
LeBoeuf, RC
机构
[1] Univ Washington, Dept Pathobiol, Seattle, WA 98195 USA
[2] AstraZeneca, Dept Biochem & Cell Biol, Molndal, Sweden
[3] Chalmers Univ Technol, Dept Math Stat, S-41296 Gothenburg, Sweden
[4] Univ Washington, Nutr Sci Program, Seattle, WA 98195 USA
关键词
mice; atherosclerosis; obesity; lipoprotein; dyslipidemia;
D O I
10.1016/j.atherosclerosis.2003.07.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aims of this study were to determine whether mice induced to become obese also exhibited accelerated atherosclerosis, and to determine whether obesity itself or dyslipidemia associated with obesity enhanced atherosclerosis. Wild-type (C57BL/6) mice and mice deficient for the low density lipoprotein receptor (LDLR-/-) or apolipoprotein E (apoE-/-) were fed a low fat, rodent chow diet or a high fat, high sucrose (diabetogenic) diet to induce obesity. As compared with wild-type mice, diabetogenic diet-fed LDLR-/- mice became more obese and developed severe dyslipidemia. Consequently, atherosclerotic lesions were increased in the LDLR-/- mice 3.7-fold over chow fed values. ApoE-/- mice showed weight gain profiles similar to those observed for wild-type mice. However, no differences in plasma lipid levels, lipoprotein profiles or atherosclerotic lesion areas were observed between chow-fed and diabetogenic diet-fed apoE-/- mice. These data demonstrate that lipid storage and partitioning as mediated by the low density lipoproteins (LDL) receptor or apoE-/- have profound and opposing consequences for dyslipidemia and atherosclerosis susceptibility associated with obesity. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:49 / 55
页数:7
相关论文
共 30 条
[1]   Obesity and coronary heart disease [J].
Alexander, JK .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2001, 321 (04) :215-224
[2]   CHOLESTEROL AND MORTALITY - 30 YEARS OF FOLLOW-UP FROM THE FRAMINGHAM-STUDY [J].
ANDERSON, KM ;
CASTELLI, WP ;
LEVY, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (16) :2176-2180
[3]  
Billington CJ, 2000, ARCH INTERN MED, V160, P898, DOI 10.1001/archinte.160.7.898
[4]   Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor [J].
Chua, SC ;
Chung, WK ;
WuPeng, XS ;
Zhang, YY ;
Liu, SM ;
Tartaglia, L ;
Leibel, RL .
SCIENCE, 1996, 271 (5251) :994-996
[5]   Treatment of diabetic dyslipidemia [J].
Garg, A .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (4A) :47B-51B
[6]   MASSIVE XANTHOMATOSIS AND ATHEROSCLEROSIS IN CHOLESTEROL-FED LOW-DENSITY-LIPOPROTEIN RECEPTOR-NEGATIVE MICE [J].
ISHIBASHI, S ;
GOLDSTEIN, JL ;
BROWN, MS ;
HERZ, J ;
BURNS, DK .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (05) :1885-1893
[7]   The db/db mouse, a model for diabetic dyslipidemia:: Molecular characterization and effects of Western diet feeding [J].
Kobayashi, K ;
Forte, TM ;
Taniguchi, S ;
Ishida, BY ;
Oka, K ;
Chan, L .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2000, 49 (01) :22-31
[8]   Increased atherosclerosis in Streptozotocin-induced diabetic mice [J].
Kunjathoor, VV ;
Wilson, DL ;
LeBoeuf, RC .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (07) :1767-1773
[9]   Abdominal obesity and its metabolic complications: implications for the risk of ischaemic heart disease [J].
Lamarche, B .
CORONARY ARTERY DISEASE, 1998, 9 (08) :473-481
[10]  
LEBOEUF RC, 1994, J LIPID RES, V35, P121